Obstetric antiphospholipid syndrome is an acquired autoimmune disorder that is associated with various obstetric complications and, in the absence of prior history of thrombosis, with the presence of antiphospholipid antibodies directed against other phospholipids, proteins called cofactors or PL-cofactor complexes. Although the obstetric complications have been related to the procoagulant properties of antiphospholipid antibodies, pathological studies of human placenta have shown the proinflammatory capacity of antiphospholipid antibodies via the complement system and proinflammatory cytokines. There is no general agreement on which antiphospholipid antibodies profile (laboratory) confers the greatest obstetric risk, but the best candidates are categories I and IIa. Combined treatment with low doses of aspirin and heparin achieves good obstetric and maternal outcomes. In this study, we also review the therapeutic possibilities in refractory cases, although the likelihood of progressing to other autoimmune diseases is low. We briefly comment on incomplete obstetric antiphospholipid syndrome, also known as antiphospholipid antibody-mediated pregnancy morbidity syndrome.
Keywords: Abortos recurrentes; Anticuerpos antifosfolipídicos; Antiphospholipid antibodies; Embarazo; Fetal loss; Obstetric antiphospholipid syndrome; Preeclampsia; Pregnancy; Pérdidas fetales; Recurrent miscarriages; Síndrome antifosfolipídico obstétrico.
Copyright © 2015 Elsevier España, S.L.U. y Sociedad Española de Medicina Interna (SEMI). All rights reserved.
Controversies concerning the antiphospholipid syndrome in obstetrics.Reumatol Clin. 2017 Jan-Feb;13(1):30-36. doi: 10.1016/j.reuma.2016.04.011. Epub 2016 Jun 10. Reumatol Clin. 2017. PMID: 27291869 Review. English, Spanish.
Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies?Obstet Gynecol Surv. 2010 Jan;65(1):39-45. doi: 10.1097/OGX.0b013e3181c97809. Obstet Gynecol Surv. 2010. PMID: 20040128 Review.
Antiphospholipid antibody syndrome.Obstet Gynecol Clin North Am. 2014 Mar;41(1):113-32. doi: 10.1016/j.ogc.2013.10.004. Obstet Gynecol Clin North Am. 2014. PMID: 24491987 Review.
Obstetric antiphospholipid syndrome: an update on pathophysiology and management.Semin Reprod Med. 2011 Nov;29(6):522-39. doi: 10.1055/s-0031-1293206. Epub 2011 Dec 8. Semin Reprod Med. 2011. PMID: 22161465 Review.
Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.Med Clin (Barc). 2018 Sep 21;151(6):215-222. doi: 10.1016/j.medcli.2017.11.017. Epub 2017 Dec 20. Med Clin (Barc). 2018. PMID: 29274674 Clinical Trial. English, Spanish.
Cited by 1 article
Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.Clin Rev Allergy Immunol. 2017 Aug;53(1):40-53. doi: 10.1007/s12016-016-8596-x. Clin Rev Allergy Immunol. 2017. PMID: 28054230 Review.